FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 316:183-186 January 22, 1987 Number 4 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

Human parvovirus is the causative agent of erythema infectiosum, a mild epidemic illness. In a recent outbreak in northeast Scotland, six women had serologic evidence of having contracted human parvovirus infection during pregnancy. Two of the women had midtrimester abortions, and both abortuses were grossly hydropic with anemia. They had similar microscopical histopathological features--a pronounced leukoerythroblastic reaction, hepatitis, excessive iron pigment in the liver, and eosinophilic changes in the hematopoietic cell nuclei. Dot hybridization with radiolabeled human parvovirus DNA probes revealed viral DNA in several tissues from both fetuses, indicating that they had been infected by the virus in utero. The remaining four women had uncomplicated pregnancies and delivered apparently healthy babies, none of whom had human parvovirus-specific IgM antibody at delivery. We conclude that this common virus may pose a serious risk to the fetus after maternal infection.

This article has been cited by other articles:

• Arechavaleta-Velasco, F., Gomez, L., Ma, Y., Zhao, J., McGrath, C.M., Sammel, M.D., Nelson, D.B., Parry, S. (2008). Adverse reproductive outcomes in urban women with adeno-associated virus-2 infections in early pregnancy. Hum Reprod 23: 29-36 [Abstract] [Full Text]  
• Stepan, H., Faber, R. (2006). Elevated sFlt1 level and preeclampsia with parvovirus-induced hydrops.. NEJM 354: 1857-1858 [Full Text]  
• Butchko, A. R., Jordan, J. A. (2004). Comparison of Three Commercially Available Serologic Assays Used To Detect Human Parvovirus B19-Specific Immunoglobulin M (IgM) and IgG Antibodies in Sera of Pregnant Women. J. Clin. Microbiol. 42: 3191-3195 [Abstract] [Full Text]  
• Young, N. S., Brown, K. E. (2004). Parvovirus B19. NEJM 350: 586-597 [Full Text]  
• Noyola, D. E., Padilla-Ruiz, M. L., Obregon-Ramos, M. G., Zayas, P., Perez-Romano, B. (2004). Parvovirus B19 infection in medical students during a hospital outbreak. J Med Microbiol 53: 141-146 [Abstract] [Full Text]  
• Xu, J., Raff, T. C., Muallem, N. S., Neubert, A. G. (2003). Hydrops Fetalis Secondary to Parvovirus B19 Infections. J Am Board Fam Med 16: 63-68 [Abstract] [Full Text]  
• Heegaard, E. D., Brown, K. E. (2002). Human Parvovirus B19. Clin. Microbiol. Rev. 15: 485-505 [Abstract] [Full Text]  
• Jordan, J. A. (2000). Comparison of a Baculovirus-Based VP2 Enzyme Immunoassay (EIA) to an Escherichia coli-Based VP1 EIA for Detection of Human Parvovirus B19 Immunoglobulin M and Immunoglobulin G in Sera of Pregnant Women. J. Clin. Microbiol. 38: 1472-1475 [Abstract] [Full Text]  
• Koike, T., Araki, S., Minakami, H., Ogawa, S., Sayama, M., Shibahara, H., Sato, I. (2000). Clinical efficacy of peritoneovenous shunting for the treatment of severe ovarian hyperstimulation syndrome. Hum Reprod 15: 113-117 [Abstract] [Full Text]  
• Musiani, M., Pasini, P., Zerbini, M., Gentilomi, G., Roda, A., Gallinella, G., Manaresi, E., Venturoli, S. (1999). Prenatal Diagnosis of Parvovirus B19-Induced Hydrops Fetalis by Chemiluminescence In Situ Hybridization. J. Clin. Microbiol. 37: 2326-2329 [Abstract] [Full Text]  
• Abuhammour, W., Abdel-Haq, N., Asmar, B. (1999). Picture of the Month. Arch Pediatr Adolesc Med 153: 87-88 [Full Text]  
• Heffner, L. J., Roberts, D. J., Nanowitz, M. (1997). Case 23-1997- A Premature Newborn Infant with Congenital Ascites. NEJM 337: 260-267 [Full Text]